AGP Executive Report
Last update: an hour agoMassachusetts Ballot: Voters will decide whether to repeal adult-use cannabis sales, a move that could dismantle an $8 billion industry and erase hundreds of millions in tax revenue; medical cannabis and limited possession would remain legal. Hemp Policy: A federal ban on hemp-derived cannabinoids scheduled for December could threaten most of the country’s 50,000 hemp operators and 225,000 jobs, according to an industry report. Medical Cannabis: Cantourage’s Canadian partner Green Karat secured EU-GMP certification, opening a route to supply medical cannabis products across Europe and the UK. Market Watch: Tilray’s quarterly revenue rose 20%, led by beverages, but cannabis sales fell to $56.1 million. Cannabinoid Research: The FDA cleared a conditional-approval pathway for a cannabinoid treatment for canine bone-cancer pain. Community Investment: Vermont cannabis retailer Magic Mann says its local and Indigenous fund has distributed more than $175,000, including over $75,000 to Indigenous communities and initiatives.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
